Treatment of postpartum hemorrhage with misoprostol

被引：25

作者：

Blum, J. ^{[1
]}

Alfirevic, Z. ^{[2
]}

Walraven, G. ^{[3
]}

Weeks, A. ^{[2
]}

Winikoff, B. ^{[1
]}

机构：

[1] Gynuity Hlth Projects, New York, NY 10010 USA

[2] Univ Liverpool, Sch Reprod & Dev Med, Liverpool L69 3BX, Merseyside, England

[3] Secretariat Son Altesse Aga Khan, Aiglemont, France

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS | 2007年 / 99卷

关键词：

misoprostol; postpartum hemorrhage;

D O I：

10.1016/j.ijgo.2007.09.013

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

A literature review was conducted to determine whether misoprostol is an effective treatment for postpartum hemorrhage (PPH) and in what dose. All English language articles published before March 2007 reporting on misoprostol for treatment of PPH were reviewed. Unpublished data previously presented at international scientific meetings were also included in the review. Little evidence exists in support of misoprostol for treatment of postpartum hemorrhage (PPH). Nonetheless, PPH remains a major killer of women worldwide, and new treatment options are widely sought. For this reason, we recommend a single dose of misoprostol 600 mu g oral or sublingual for PPH treatment in instances when other treatments have either failed to work or are not available. (C) 2007 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

引用

页码：S202 / S205

页数：4

共 27 条

[21] Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta [J].